10:23:58 Europe / Stockholm

Bifogade filer

Kurs & Likviditet

Kursutveckling och likviditet under dagen för detta pressmeddelande

Kalender

2025-04-29 Årsstämma 2025
2025-04-29 Kvartalsrapport 2025-Q1
2025-02-28 Bokslutskommuniké 2024
2024-10-31 Kvartalsrapport 2024-Q3
2024-07-31 Kvartalsrapport 2024-Q2
2024-04-30 Ordinarie utdelning NNH 0.00 SEK
2024-04-29 Årsstämma 2024
2024-04-29 Kvartalsrapport 2024-Q1
2024-02-28 Bokslutskommuniké 2023
2023-10-31 Kvartalsrapport 2023-Q3
2023-07-31 Kvartalsrapport 2023-Q2
2023-04-28 Ordinarie utdelning NNH 0.00 SEK
2023-04-27 Kvartalsrapport 2023-Q1
2023-04-27 Årsstämma 2023
2023-02-28 Bokslutskommuniké 2022
2022-10-28 Kvartalsrapport 2022-Q3
2022-07-29 Kvartalsrapport 2022-Q2
2022-04-29 Ordinarie utdelning NNH 1.25 SEK
2022-04-28 Kvartalsrapport 2022-Q1
2022-04-28 Årsstämma 2022
2022-02-28 Bokslutskommuniké 2021
2021-10-29 Kvartalsrapport 2021-Q3
2021-07-30 Kvartalsrapport 2021-Q2
2021-04-30 Ordinarie utdelning NNH 1.50 SEK
2021-04-29 Kvartalsrapport 2021-Q1
2021-04-29 Årsstämma 2021
2021-02-26 Bokslutskommuniké 2020
2020-10-30 Kvartalsrapport 2020-Q3
2020-07-31 Kvartalsrapport 2020-Q2
2020-04-30 Ordinarie utdelning NNH 1.75 SEK
2020-04-29 Kvartalsrapport 2020-Q1
2020-04-29 Årsstämma 2020
2020-02-28 Bokslutskommuniké 2019
2019-10-31 Kvartalsrapport 2019-Q3
2019-07-31 Kvartalsrapport 2019-Q2
2019-04-29 Ordinarie utdelning NNH 1.50 SEK
2019-04-25 Kvartalsrapport 2019-Q1
2019-04-25 Årsstämma 2019
2019-03-01 Bokslutskommuniké 2018
2018-10-31 Kvartalsrapport 2018-Q3
2018-07-31 Kvartalsrapport 2018-Q2
2018-04-27 Ordinarie utdelning NNH 1.15 SEK
2018-04-26 Kvartalsrapport 2018-Q1
2018-04-26 Årsstämma 2018
2018-03-02 Bokslutskommuniké 2017
2017-10-31 Kvartalsrapport 2017-Q3
2017-07-31 Kvartalsrapport 2017-Q2
2017-04-28 Ordinarie utdelning NNH 0.40 SEK
2017-04-27 Kvartalsrapport 2017-Q1
2017-04-27 Årsstämma 2017
2017-03-06 Bokslutskommuniké 2016
2016-10-31 Kvartalsrapport 2016-Q3
2016-07-29 Kvartalsrapport 2016-Q2
2016-04-29 Ordinarie utdelning NNH 0.25 SEK
2016-04-28 Årsstämma 2016
2016-04-28 Kvartalsrapport 2016-Q1
2016-03-07 Bokslutskommuniké 2015
2015-10-30 Kvartalsrapport 2015-Q3
2015-07-31 Kvartalsrapport 2015-Q2
2015-04-30 Ordinarie utdelning NNH 0.00 SEK
2015-04-29 Kvartalsrapport 2015-Q1
2015-04-29 Årsstämma 2015
2015-03-06 Bokslutskommuniké 2014
2014-10-31 Kvartalsrapport 2014-Q3
2014-07-31 Kvartalsrapport 2014-Q2
2014-05-01 Ordinarie utdelning NNH 0.00 SEK
2014-04-30 Årsstämma 2014
2014-03-07 Bokslutskommuniké 2013
2013-10-31 Kvartalsrapport 2013-Q3
2013-07-31 Kvartalsrapport 2013-Q2
2013-04-30 Ordinarie utdelning NNH 0.00 SEK
2013-04-29 Årsstämma 2013
2013-04-29 Kvartalsrapport 2013-Q1
2013-03-08 Bokslutskommuniké 2012
2012-10-31 Kvartalsrapport 2012-Q3
2012-07-31 Kvartalsrapport 2012-Q2
2012-05-01 Ordinarie utdelning NNH 0.00 SEK
2012-04-30 Årsstämma 2012
2012-04-30 Kvartalsrapport 2012-Q1
2012-03-09 Bokslutskommuniké 2011
2011-10-31 Kvartalsrapport 2011-Q3
2011-07-29 Kvartalsrapport 2011-Q2
2011-04-29 Kvartalsrapport 2011-Q1
2011-04-29 Årsstämma 2011
2011-03-11 Bokslutskommuniké 2010
2010-10-29 Kvartalsrapport 2010-Q3
2010-07-30 Kvartalsrapport 2010-Q2
2010-05-03 Ordinarie utdelning NNH 0.00 SEK
2010-04-30 Kvartalsrapport 2010-Q1
2010-02-26 Bokslutskommuniké 2009
2009-10-30 Kvartalsrapport 2009-Q3
2009-07-31 Kvartalsrapport 2009-Q2
2009-04-30 Kvartalsrapport 2009-Q1
2009-04-16 Årsstämma 1
2009-04-14 Ordinarie utdelning NNH 0.00 SEK

Beskrivning

LandSverige
ListaFirst North Stockholm
SektorHandel & varor
IndustriDetaljhandel
New Nordic Healthbrands är specialiserat mot att utveckla och marknadsföra kosttillskott och naturläkemedel. Största delen av sortimentet utgörs av hälsofrämjande örter. Produkterna säljs via bolagets återförsäljare och tillskotten används exempelvis inom hud- och hårvård, för förbättring av immunsystemet och synförmågan, samt som generella vitamintillskott. Huvudkontoret ligger i Malmö.
2015-07-31 09:00:08

 SIX MONTHS 2015
· Net sales amounted to MSEK 149.4 (136.0), an increase of 9.9 percent. In local currencies, the increase was 2.9 percent.
· Gross margin increased to 66.6 percent (64.6).
· EBITDA increased to MSEK 8.9 (8.4).
· Operating profit improved to MSEK 7.6 (7.1).
· Profit after tax for the period improved to MSEK 5.3 (5.0).
· Earnings per share increased to SEK 0.86 (0.80).

Q2 2015
· Net sales amounted to MSEK 76.5 (74.9), an increase of 2.1 percent. In local currencies, the sales decreased 3.9 percent.
· Gross margin increased to 66.5 percent (64.6).
· EBITDA decreased to MSEK 4.2 (4.7).
· Operating profit decreased to MSEK 3.5 (4.0).
· Profit after tax for the period idecreased to MSEK 2.2 (2.9).
· Earnings per share decreased to SEK 0.36 (0.47).

COMMENTS BY KARL KRISTIAN BERGMAN JENSEN, CEO

Sales increased 9.9 percent to SEK 149.4 million during the first six months of the year. In local currencies, sales increased 2.9 percent. EBITDA increased to EUR 8.9 million and earnings per share after tax increased to 0.86 SEK.

We grew in all geographic areas. The countries that have contributed most to our absolute growth in sales is US, UK and Denmark. Although most markets have had success, there are some markets where growth does not match our ambitions and markets where we even experienced a slight decrease. It was particularly notable in the second quarter. Where growth has not met our expectations it has been due to a combination of several marketspecific conditions. Some of these challenges we can solve relatively quickly and so we do. In other cases, we rely on external factors, and these take longer to adjust to. The effectiveness of our marketing, our cooperation with retailers and the success of our new product launches will be decisive for our performance. Our product portfolio is well tuned and further innovations are planned for introduction in the fall. The launch of Nordic Organic Fish Oil™ has been well received on the Danish market. Launch of this product is planned in a number of additional markets in the second half of 2015.

Our costs are under control. Our gross margin increased during the first half of 2015 to nearly 67 per cent and it is now at a satisfactory level. We have increased our staff from 37 to 43 people so we are better prepared for future growth. We also increased our marketing expenses to support the broadened product portfolio and our efforts to take more market share.

On 5 October this year, New Nordic can celebrate its 25th anniversary. Our growth from nothing but an idea to what New Nordic stands for today demonstrate the effectiveness of our strategy. A strategy that builds on the strengths of our brands and an entrepreneurial spirit. All employees are passionate about our business and our international expansion and I look forward to the second part of 2015 and the next 25 years with optimism.

Karl Kristian Bergman Jensen, CEO

New Nordic Healthbrands AB
Södra Förstadsgatan 3 C
SE-211 43 Malmö, SWEDEN

The information in this press release is that which New Nordic Healthbrands AB (publ) is required to disclose under Sweden's Securities Market Act. It will be released for publication at 9.00 (CET) on July 31st, 2015.

For a full report see attached pdf.

Malmö July 31, 2015

Contact:
Karl Kristian Bergman Jensen, CEO +46 40-239520 (switchboard),
Marinus Blåbjerg Sørensen, CFO +45 46323344 (switchboard)

New Nordic Healthbrands AB (publ)
SE-211 43 Malmö, Sweden
Phone +46-40-239520
fax: +46-40-239522
email: info@newnordic.se
Registered office: Malmö
Reg. No. 556698-0453

The following documents can be retrieved from beQuoted
New Nordic Delarsrapport Q2 2015-07-31.pdf
New Nordic Pressrelease 2015-07-31.pdf
New Nordic Interim Report Q2 2015-07-31.pdf

About New Nordic
New Nordic Healthbrands AB (publ) was founded in 1990 and is quoted on NASDAQ OMX Stockholm since 2007. The company's business concept is to offer the most effective and safe food supplements and natural medicines for specific health conditions. New Nordic's branded products are now available in 32 countries in pharmacies and health stores. The New Nordic Group has it's own small sales and marketing companies in most European Countries, Canada and the US, to organize local marketing campaigns, serve the pharmacy and health retailers and serve the end consumers. In 2014, sales were 272 MSEK. All New Nordic products sold worldwide are manufactured in Scandinavia. For further information, visit www.newnordic.com.